Article Versions Notes

Wang S, Malebari AM, Greene TF, O’Boyle NM, Fayne D, Nathwani SM, Twamley B, McCabe T, Keely NO, Zisterer DM, et al. 3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals. 2019; 12(2):56. https://doi.org/10.3390/ph12020056

Wang, Shu, Azizah M. Malebari, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Niall O. Keely, Daniela M. Zisterer, and et al. 2019. "3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells" Pharmaceuticals 12, no. 2: 56. https://doi.org/10.3390/ph12020056

Wang, S., Malebari, A. M., Greene, T. F., O’Boyle, N. M., Fayne, D., Nathwani, S. M., Twamley, B., McCabe, T., Keely, N. O., Zisterer, D. M., & Meegan, M. J. (2019). 3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals, 12(2), 56. https://doi.org/10.3390/ph12020056